(click on headers to sort columns)

Author(↓)	Class(↓)	Name(↓)	Type(↓)	Date(↓)	Affiliation(↓)
Oaks Z	GENE	TALDO1 (transaldolase 1)	CREATED	2013-07	Departments of Medicine, Microbiology,, Immunology, Biochemistry, Molecular Biology, Neuroscience, Physiology,, Pathology, SUNY Upstate Medical University, Syracuse, New York, USA
Obaya AJ	GENE	ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 12)	CREATED	2013-07	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Obaya AJ	GENE	ADAMTS15 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 15)	CREATED	2014-02	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Obaya AJ	GENE	FBLN2 (fibulin 2)	CREATED	2014-10	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Departamento de Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Oberley M	GENE	E2F6 (E2F transcription factor 6)	CREATED	2004-03	McArdle Laboratory for Cancer Research, University of Wisconsin - Madison, 1400 University Ave. Madison, WI 53706, USA
Ochi K	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
O'Connor R	GENE	FOXO1 (Forkhead box O1)	CREATED	2008-05	Department of Pathology, Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
O'Connor S	DEEP_INSIGHT	Guidance for reporting the interpretation of cytogenomic test results in haematological neoplasms	CREATED	2019-05	GenQA, John Radcliffe Hospital, Oxford, UK (KR, RH), Department of Genetics University Medical Center Groningen, University of Groningen, Groningen, The Netherlands(EvdB); MLL-Munich Leukemia Laboratory, Munich, Germany (CH); Department of Clinical Genetics, Erasmus MC, University medical center Rotterdam, Rotterdam, The Netherlands (BB); Laboratori de Citogenètica Molecular, Servei de Patologia, Grup de Recerca,Translacional en Neoplàsies Hematològiques, Cancer Research Program,Hospital del Mar, Barcelona, Spain (BE); Viapath Genetics laboratory, Guys Hospital, London, UK (NF); Department of Cytogenetics, City Hospital Campus, Nottingham, UK (KM); Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK (SOC); Laboratoire d'oncogénomique, Service d'hématologie Centre Hospitalier Universitaire, Vaudois, Switzerland (JS); Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK (PT); Laboratorio di Citogenetica e Genetica Molecolare - Laboratorio Analisi, Humanitas Research Hospital, Rozzano, Milan, Italy (SS); Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University,Prague, Czech Republic (ZZ); Laboratoire d'Hématologie, IUCT-O, Toulouse, France (IL). Corresponding author: Katrina Rack
Odero MD	CHROM_CLIN	t(5;12)(q31;p13) ETV6/ACSL6 in MDS,AML and AEL	CREATED	2007-03	Departamento de Genetica, Facultades de Ciencias y Medicina, y Area de Oncologia, Centro de Investigacion Medica Aplicada (CIMA), Universidad de Navarra, 31008-Pamplona, Espana
Odero MD	CHROM_CLIN	t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies	CREATED	2006-08	Departamento de Genética, Facultad de Ciencias Àrea de Oncología, Centro de Investigaciò_n Médica Aplicada (CIMA) Universidad de Navarra, 31008 Pamplona, España
Odero MD	CHROM_CLIN	t(12;18)(p13;q12) ETV6/SETBP1	CREATED	2012-03	Division of Oncology, CIMA, University of Navarra, E-31008 Pamplona, Spain (IC, LGO, MDO); Department of Genetics, School of Sciences, University of Navarra, E-31008 Pamplona, Spain (IC, PA, MJC, MDO)
Odero MD	GENE	SETBP1 (SET binding protein 1)	CREATED	2012-09	Translational Oncology Division, Health Research Institute, Oncology Department, University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, E-28040 Madrid, Spain (IC); Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, E-31008 Pamplona, Spain (LGO, MDO); Department of Genetics, School of Sciences, University of Navarra E-31008 Pamplona, Spain (MDO)
O'Donovan DS	GENE	SFRP2 (secreted frizzled-related protein 2)	CREATED	2013-08	Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College, Dublin, Ireland
Ogawa M	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
Ogita H	GENE	ACTN4 (actinin, alpha 4)	CREATED	2013-04	Department of Biochemistry, Molecular Biology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan
Ohgami RS	CHROM_CLIN	del (5q) solely in Myelodysplastic syndrome	CREATED	2016-10	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami R S	CHROM_CLIN	Follicular Dendritic Cell Sarcoma	CREATED	2016-11	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami RS	CHROM_CLIN	Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)	CREATED	2016-10	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami RS	CHROM_CLIN	Pediatric-type Follicular Lymphoma	CREATED	2016-05	Department of Pathology, Stanford University, Stanford, CA, USA. ROhgami@stanfordhealthcare.org
Ohno N	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
Ohnuma K	GENE	DPP4 (dipeptidyl-peptidase 4)	CREATED	2012-11	Department of Therapy Development, Innovation for Immune disorders, Cancers, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Okamoto K	GENE	RIOX2 (ribosomal oxygenase 2)	CREATED	2010-04	Laboratory of Molecular, Cellular Biology, Department of Molecular Pharmacology, Faculty of Pharmacy, Takasaki University of Health, Welfare, 60 Nakaorui-machi, Takasaki-shi, Gunma 370-0033, Japan
Okkeri J	GENE	KIAA1524	CREATED	2010-01	Centre for Biotechnology, University of Turku, Abo Akademi, Tykistokatu 6A, 20520 Turku, Finland (JO, JW); Institute of Medical Technology, University of Tampere, Biokatu 6-8, 33520 Tampere, Finland (AK)
Olalla Saad ST	GENE	ARHGAP21 (Rho GTPase activating protein 21)	CREATED	2016-12	Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas (MFP, STOS, ML); Department of Biological Sciences, Federal University of São Paulo, Diadema (ML), Brazil. lazarini@unifesp.br; marilazarini@gmail.com
Olazabal-Herrero A	GENE	WDR48 (WD repeat domain 48)	CREATED	2017-04	Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain; ane.olazabal@ehu.eus; josean.rodriguez@ehu.eus (AOH, JAR); Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands; gj.peters@vumc.nl; elisa.giovannetti@gmail.com (GJP, EG); Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa , Italy (EG).
Olgun	GENE	SNW1 (SNW domain containing 1)	CREATED	2017-08	Middle East Technical University, Department of Biological Sciences, Cankaya 06800, Ankara, Turkey; colgun@metu.edu.tr; mmuyan@metu.edu.tr
Oliva J	GENE	UBD (ubiquitin D)	CREATED	2011-11	Department of Hematology, LA Biomed, Torrance, CA 90502, USA (JA); Department of Pathology, LA BioMed, Torrance, CA 90502, USA (SWF)
Oliveira AM	GENE	USP6 (ubiquitin specific protease 6 (Tre-2 oncogene))	CREATED	2005-04	Department of Pathology, Laboratory Medicine, Mayo Clinic, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
Oliveira DT	GENE	ADRB2 (adrenoceptor beta 2, surface)	CREATED	2014-02	Department of Stomatology, Area of Pathology, Bauru School of Dentistry - University of Sao Paulo, Bauru, Brazil
Olivieri C	GENE	ACVRL1 (activin A receptor type II-like 1)	CREATED	2014-03	Dept of Molecular Medicine, Unit of General Biology, Medical Genetics, University of Pavia, Italy (FO, SP, CO); Dept of Molecular Medicine, Unit of Immunology, General Pathology, University of Pavia, Italy (LV, CS)
Olivier M	GENE	TP53 (Tumour protein p53 (Li-Fraumeni syndrome))	UPDATED	2007-04	Molecular Carcinogenesis, Biomarkers Group, International Agency for Research on Cancer (IARC/CIRC), 150 Cours Albert Thomas, F-69372 Lyon CEDEX 08, France
Oliviero S	GENE	VEGFD (c-fos induced growth factor (vascular endothelial growth factor D))	CREATED	2012-05	Department of Molecular Biology, University of Siena, Italy
O'Loghlen A	GENE	CBX7 (chromobox homolog 7)	CREATED	2011-11	Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London W12 0NN, UK
Olschwang S	K_PRONE	Familial adenomatous polyposis (FAP)	CREATED	1998-06	INSERM U434, Fondation Jean Dausset - C.E.P.H., 27, rue Juliette Dodu, 75010 Paris, France
Olshanskaya Y	CHROM_CLIN	ins(X;11)(q28;q23q23) KMT2A/FLNA	DATE	2018-11
Olshanskaya Y	CHROM_CLIN	t(11;16)(q23;q24) KMT2A/USP10	CREATED	2018-12	Dmitry Rogachev Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Samora Mashela str., 1, Moscow, 117997, Russia (EZ, AK, PB, GN, MM, AM, YuO), Lomonosov Moscow State University, GSP-1, Leninskie Gory, Moscow, 119991, Russia (SL), Goethe-University of Frankfurt, Diagnostic Center of Acute Leukemia, Biocenter, Max-von-Laue-Str., 9, D-60438, Frankfurt / Main, Germany (CM, RM) / eazerkalenkova@gmail.com
Omabe M	DEEP_INSIGHT	Insight in inflammation and cancer	CREATED	2013-10	Molecular Cancer Biology Research Group, Molecular Pathology, Immunology Division, Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University Nigeria (MO); Department of cancer studies, Molecular medicine, University of Leicester, United Kingdom (NOK)
O'Neill AK	GENE	PHLPP1 (PH domain leucine-rich repeat protein phosphatase 1)	CREATED	2009-06	Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., 0721, La Jolla, CA 92093, USA
O'Neill AK	GENE	PHLPP2 (PH domain leucine-rich repeat protein phosphatase 2)	CREATED	2009-06	Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., Mail Code 0721, La Jolla, CA 92093, USA
Onodera Y	GENE	ASAP1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 1)	CREATED	2012-02	Hokkaido University Graduate School of Medicine, Department of Molecular Biology, Sapporo, Japan
Orlandini M	GENE	DAB2 (disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila))	CREATED	2009-05	Department of Molecular Biology, Via Fiorentina 1, 53100 - Siena, Italy
Ornati F	GENE	ACVRL1 (activin A receptor type II-like 1)	CREATED	2014-03	Dept of Molecular Medicine, Unit of General Biology, Medical Genetics, University of Pavia, Italy (FO, SP, CO); Dept of Molecular Medicine, Unit of Immunology, General Pathology, University of Pavia, Italy (LV, CS)
Orso F	GENE	TFAP2A (transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha))	CREATED	2009-09	Molecular Biotechnology Center (MBC), Department of Oncological Sciences, University of Torino, Via Nizza, 52, 10126 Torino, Italy (FO, DT); Center for Complex Systems in Molecular Biology, Medicine, University of Torino, Via Acc Albertina, 13, 10023 Torino, Italy (FO, DT)
Ostrowski J	GENE	HNRNPK (heterogeneous nuclear ribonucleoprotein K)	CREATED	2009-03	Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology Warsaw, Poland
Ottaviani A	DEEP_INSIGHT	Dynamics and plasticity of chromosome ends: consequences in human pathologies	CREATED	2009-06	Laboratoire de Biologie Moléculaire de la Cellule, CNRS UMR5239, Ecole Normale Supérieure de Lyon, UCBL1, IFR128. 46 allée d'Italie, 69364 Lyon Cedex 07, France
Ouadid-Ahidouch H	GENE	ORAI3 (ORAI calcium release-activated calcium modulator 3)	CREATED	2014-06	University of Picardie Jules Verne, UFR Sciences, EA 4667, Laboratory of Cell, Molecular Physiology, SFR CAP-SANTE (FED 4231), Amiens, France (JH, NB, MF, ASA, PK, FH, HS, AA, HOA); University of Picardie Jules Verne, Amiens University Hospital, Department of Pathology, Tumor Bank of Picardie, Amiens, France (NB, HS); Department of Biology, Faculty of Sciences, University Ibn Zohr, Agadir, Morocco (AA)
Ouahchi K	CASE_REPORT_HEMAT	t(16;21)(q24;q22) in therapy-related acute myelogenous leukemia arising from myelodysplastic syndrome	CREATED	2007-02	Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
Ouban A	DEEP_INSIGHT	The Claudins family: Structure and function in normal and pathologic conditions	CREATED	2012-07	Department of Pathology, College of Medicine, Prince Salman University, Kharj, Kingdom of Saudi Arabia (AO); Department of Pathology, Children's Mercy Hospital, University of Kansas, Kansas City, Missouri, USA (AAA)
Ouchida M	GENE	SS18 (synovial sarcoma translocation, chromosome 18)	CREATED	2006-05	Department of Molecular Genetics, Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, Okayama University. Shikata-cho 2-5-1, Okayama 700-8558, Japan
Ouertani A	GENE	PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4)	CREATED	2013-04	German Cancer Research Center (DKFZ), Department of Molecular Genetics, Heidelberg, Germany
Ou SH	GENE	ROS1 (ROS proto-oncogene 1 , receptor tyrosine kinase)	CREATED	2014-01	University of California Irvine Medical Center, Orange, CA. sklempne@uci.edu; siou@uci.edu
Ouwens DM	GENE	AKT1S1 (AKT1 substrate 1 (proline-rich))	CREATED	2014-11	German Diabetes Centre, Institute for Clinical Biochemistry, Pathobiochemistry, Duesseldorf, Germany (CW, DMO); German Centre for Diabetes Research (DZD e.V.), Partner Duesseldorf, Germany (CW, DMO); Department of Human Biology, Maastricht University Medical Center, Maastricht, The Netherlands (EBMN); Department of Endocrinology, Ghent University Hospital, Ghent, Belgium (DMO); Department of Internal Medicine, division 1, University Hospital Cologne, Cologne, Germany (CW)
Ovechkina V	CASE_REPORT_HEMAT	t(6;8)(q27;p12) in a new case "8p11 myeloproliferative syndrome"	CREATED	2011-11	I.P.Pavlov State Medical University, R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, Cytogenetic Laboratory, Saint Petersburg, Russia
Ovechkina V	CASE_REPORT_HEMAT	A new case of Acute Myeloid Leukemia with semi-cryptic t(7;21)(p22;q22)	CREATED	2012-04	I.P. Pavlov State Medical University, R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, Cytogenetic Laboratory, Saint Petersburg, Russia (TG, IB, MV, EN, IP, VO, TS); City Children's Hospital No.1, Saint Petersburg, Russia (EB, IG)
Owen H	GENE	MBD2 (methyl CpG binding domain protein 2)	CREATED	2009-10	Wellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, King's Buildings, Mayfield Road, Edinburgh EH9 3JR, UK
Owen LA	GENE	NKX2-2 (NK2 homeobox 2)	CREATED	2008-01	Department of Oncological Sciences, University of Utah School of Medicine, Center for Children, Huntsman Cancer Institute,, Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Oyken M	GENE	ALCAM (Activated Leukocyte Cell Adhesion Molecule)	CREATED	2017-06	Esra Yavuz: Department of Biological Sciences, Middle East Technical University, Ankara, Turkey, yavuzesra3@gmail.com; oyken.merve@metu.edu.tr; erson@metu.edu.tr
Ozawa MG	CHROM_CLIN	Pediatric-type Follicular Lymphoma	CREATED	2016-05	Department of Pathology, Stanford University, Stanford, CA, USA. ROhgami@stanfordhealthcare.org
Ozkayar O	GENE	EEF2K (eukaryotic elongation factor 2 kinase)	CREATED	2016-01	University of Texas-Houston-MD Anderson Cancer Center, Department of Experimental Therapeutics, 1515 Holcombe Boulevard, Unit 422, Houston, TX7730; Bozpolat@mdanderson.org
Ozpolat B	GENE	EEF2K (eukaryotic elongation factor 2 kinase)	CREATED	2016-01	University of Texas-Houston-MD Anderson Cancer Center, Department of Experimental Therapeutics, 1515 Holcombe Boulevard, Unit 422, Houston, TX7730; Bozpolat@mdanderson.org